Thromboembolic and neurologic sequelae of discontinuation of an antihyperlipidemic drug during ongoing warfarin therapy

Warfarin and antihyperlipidemics are commonly co-prescribed. Some antihyperlipidemics may inhibit warfarin deactivation via the hepatic cytochrome P450 system. Therefore, antihyperlipidemic discontinuation has been hypothesized to result in underanticoagulation, as warfarin metabolism is no longer i...

Descripción completa

Detalles Bibliográficos
Autores principales: Leonard, Charles E., Brensinger, Colleen M., Bilker, Warren B., Kimmel, Stephen E., Whitaker, Heather J., Hennessy, Sean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740131/
https://www.ncbi.nlm.nih.gov/pubmed/29269848
http://dx.doi.org/10.1038/s41598-017-18318-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740131/
https://www.ncbi.nlm.nih.gov/pubmed/29269848
http://dx.doi.org/10.1038/s41598-017-18318-6

Ejemplares similares